Literature DB >> 9857071

Nuclear sterol regulatory element-binding proteins activate genes responsible for the entire program of unsaturated fatty acid biosynthesis in transgenic mouse liver.

I Shimomura1, H Shimano, B S Korn, Y Bashmakov, J D Horton.   

Abstract

Previous studies have shown that the rate of fatty acid synthesis is elevated by more than 20-fold in livers of transgenic mice that express truncated nuclear forms of sterol regulatory element-binding proteins (SREBPs). This was explained in part by an increase in the levels of mRNA for the two major enzymes of fatty acid synthesis, acetyl-CoA carboxylase and fatty acid synthase, whose transcription is stimulated by SREBPs. Fatty acid synthesis also requires a source of acetyl-CoA and NADPH. In the current studies we show that the levels of mRNA for ATP citrate lyase, the enzyme that produces acetyl-CoA, are also elevated in the transgenic livers. In addition, we found marked elevations in the mRNAs for malic enzyme, glucose-6-phosphate dehydrogenase, and 6-phosphogluconate dehydrogenase, all of which produce NADPH. Finally, we found that overexpressing two of the SREBPs (1a and 2) led to elevated mRNAs for stearoyl-CoA desaturase 1 (SCD1), an isoform that is detectable in nontransgenic livers, and SCD2, an isoform that is not detected in nontransgenic livers. This stimulation led to an increase in total SCD activity in liver microsomes. Together, all of these changes would be expected to lead to a marked increase in the concentration of monounsaturated fatty acids in the transgenic livers, and this was confirmed chromatographically. We conclude that expression of nuclear SREBPs is capable of activating the entire coordinated program of unsaturated fatty acid biosynthesis in mouse liver.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9857071     DOI: 10.1074/jbc.273.52.35299

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  95 in total

Review 1.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

Authors:  Jay D Horton; Joseph L Goldstein; Michael S Brown
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

2.  Role of LXRs in control of lipogenesis.

Authors:  J R Schultz; H Tu; A Luk; J J Repa; J C Medina; L Li; S Schwendner; S Wang; M Thoolen; D J Mangelsdorf; K D Lustig; B Shan
Journal:  Genes Dev       Date:  2000-11-15       Impact factor: 11.361

3.  SREBP isoform and SREBP target gene expression during rat primary hepatocyte culture.

Authors:  Jiakai Wu; Alan J Dickson
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-06-22       Impact factor: 2.416

4.  Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.

Authors:  Minsheng Yuan; Elizabeth Pino; Lianfeng Wu; Michael Kacergis; Alexander A Soukas
Journal:  J Biol Chem       Date:  2012-07-07       Impact factor: 5.157

5.  Fatty liver in chronic hepatitis C infection: unravelling the mechanisms.

Authors:  Jude A Oben; Emma Paulon
Journal:  Gut       Date:  2007-09       Impact factor: 23.059

6.  Sterol Regulatory Element Binding Protein Regulates the Expression and Metabolic Functions of Wild-Type and Oncogenic IDH1.

Authors:  Stéphane J H Ricoult; Christian C Dibble; John M Asara; Brendan D Manning
Journal:  Mol Cell Biol       Date:  2016-08-26       Impact factor: 4.272

7.  Combined analysis of oligonucleotide microarray data from transgenic and knockout mice identifies direct SREBP target genes.

Authors:  Jay D Horton; Nila A Shah; Janet A Warrington; Norma N Anderson; Sahng Wook Park; Michael S Brown; Joseph L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-25       Impact factor: 11.205

8.  Fatty Acid de Novo Synthesis in Adult Intrauterine Growth-Restricted Offspring, and Adult Male Response to a High Fat Diet.

Authors:  Jennifer K Yee; Guang Han; Juan Vega; Wai-Nang P Lee; Michael G Ross; Mina Desai
Journal:  Lipids       Date:  2016-09-22       Impact factor: 1.880

9.  Targeting stearoyl-CoA desaturase 1 to repress endometrial cancer progression.

Authors:  Weihua Li; Huimin Bai; Shiping Liu; Dongyan Cao; Hongying Wu; Keng Shen; Yanhong Tai; Jiaxin Yang
Journal:  Oncotarget       Date:  2018-01-24

Review 10.  Molecular mediators of hepatic steatosis and liver injury.

Authors:  Jeffrey D Browning; Jay D Horton
Journal:  J Clin Invest       Date:  2004-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.